Quercetin, a Lead Compound against Type 2 Diabetes Ameliorates Glucose Uptake via AMPK Pathway in Skeletal Muscle

R Dhanya1, A D Arya2, P Nisha1

  • 1Agroprocessing and Technology Division, National Institute for Interdisciplinary Science and Technology, Council of Scientific and Industrial ResearchPappanamcode, India.

Insights

The citrus flavonoid, quercetin, enhances glucose uptake in muscle cells by activating the adenosine monophosphate kinase (AMPK) pathway, not the insulin pathway. This mechanism offers potential for managing type 2 diabetes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Metabolism

Background:

  • Skeletal muscle glucose uptake is critical for metabolic health.
  • Insulin resistance underlies type 2 diabetes, necessitating novel therapeutic targets.
  • Flavonoids, like quercetin, are plant compounds with potential health benefits.

Purpose of the Study:

  • To elucidate the molecular mechanism by which quercetin influences glucose uptake in skeletal muscle cells.
  • To determine if quercetin's effects involve the insulin signaling pathway or alternative mechanisms.
  • To explore quercetin's potential as a therapeutic agent for type 2 diabetes.

Main Methods:

  • Utilized L6 myotubes (skeletal muscle cells) as an in vitro model.
  • Employed protein kinase inhibitors to dissect signaling pathways.
  • Measured 2-NBDG uptake to assess glucose uptake.
  • Analyzed cellular AMP/ATP ratios and mitochondrial membrane potential.
  • Investigated intracellular calcium levels.

Main Results:

  • Quercetin-induced glucose uptake in L6 myotubes is independent of the insulin signaling pathway.
  • Quercetin activates the adenosine monophosphate kinase (AMPK) pathway and its downstream target p38 MAPK.
  • AMPK activation correlates with increased cellular AMP/ATP ratio and altered mitochondrial membrane potential.
  • Quercetin elevates intracellular calcium, suggesting a role for calcium-calmodulin-dependent protein kinase kinase (CaMKK).

Conclusions:

  • Quercetin promotes glucose uptake in skeletal muscle cells via the AMPK/p38 MAPK pathway, bypassing the insulin signaling pathway.
  • The mechanism is similar to that of metformin, suggesting quercetin's potential for type 2 diabetes management.
  • Quercetin may correct insulin resistance by facilitating GLUT4 translocation independently of insulin regulation.

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
786
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
739
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.5K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.7K